vimarsana.com

This randomized clinical trial assesses the efficacy and safety of a repeated low-level red-light intervention in preventing incident myopia among children in C

Related Keywords

Helsinki ,Eteläuomen Läi ,Finland ,Melbourne ,Victoria ,Australia ,Shanghai ,China ,Hongqiao ,Sichuan ,Taiwan ,Guangzhou ,Guangdong ,Mingguang ,Jiangsu ,Chinese ,Xun Xu ,Iolmaster Carl Zeiss Meditec ,Xieyi Weishikang ,Eyerising Ltd ,National Key Rd Program Of China ,Treatment Center ,International Myopia Institute ,Technology Commission ,Outstanding Academic Technical Leaders Program ,Eyerising International Pty Ltd ,Suzhou Xuanjia Optoelectronics Technology ,Hospital Ethics Committee ,Department Of Clinical Research ,China National Medical Products Administration ,Institute Inc ,Technology Commission Clinical Research ,R Group For Statistical Computing ,Centre For Eye Research Australia ,Innovation Research Project Of Shanghai Science ,National Natural Science Foundation Of China ,Southeast Asia ,Shanghai General Hospital Ethics Committee ,Consolidated Standards ,Reporting Trials ,Statistical Computing ,China National Medical Products ,Compliance Monitoring ,Early Treatment Diabetic Retinopathy Study ,Guangzhou Xieyi Weishikang ,Carl Zeiss Meditec ,Subgroup Analyses ,Myopia Incidence ,Myopic Shift ,Clinical Research ,Shanghai Eye Disease Prevention ,Shanghai Eye Hospital ,Shanghai Vision Health Center ,Shanghai Children Myopia Institute ,Eye Research Australia ,Royal Victorian Eye ,Ear Hospital ,Interest Disclosures ,Drs Zhu ,Eyerising International Pty ,National Key Rd Program ,National Natural Science Foundation ,Technology Innovation Action ,Technical Leaders Program ,Medical Innovation Research Project ,Shanghai Science ,

© 2025 Vimarsana

vimarsana.com © 2020. All Rights Reserved.